Dr. C. Michael Gibson and Dr. Serge Korjian Discuss: CSL112 (Apolipoprotein A-I) Infusions And Cardiovascular Outcomes In Patients With Acute Myocardial Infarction (ApoA-I Event Reducing In Ischemic Syndromes II (AEGIS-II) Trial): Primary Trial Results April 6, 2024 Disclosures: TBD
Dr. Javed Butler and Dr. C. Michael Gibson Discuss: Empagliflozin After Acute Myocardial Infarction: Results Of The EMPACT-MI Trial April 6, 2024 Disclosures: TBD
Dr. Gregg Stone and Dr. C. Michael Gibson Discuss: A Double-blind, Randomized Placebo Procedure-controlled Trial Of An Interatrial Shunt In Patients With HfrEF And HfpEF: Principal Results From The RELIEVE-HF Trial April 6, 2024 Disclosures: TBD
Dr. Robert Yeh and Dr. C. Michael Gibson Present: AGENT IDE Trial Results April 3, 2024 Disclosures: TBD
Dr. Michael Nanna and Dr. Gibson discuss the PRECISE trial. February 14, 2024 Disclosures: s/b HeartFlow
Dr. DJ Lakkireddy and Dr. C Michael Gibson present: newest clinical guidelines released for preventing and optimally managing atrial fibrillation February 12, 2024 Disclosures: TBD
Dr. Pam Taub and Dr. C. Michael Gibson Present: Prevention and Cardiometabolic Disease 2023 Year in Review January 4, 2024 Disclosures: TBD
